Testing and Treating the Missing Millions with Tuberculosis

article has not abstract

Vyšlo v časopise: Testing and Treating the Missing Millions with Tuberculosis. PLoS Med 12(3): e32767. doi:10.1371/journal.pmed.1001805
Kategorie: Editorial
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001805

Souhrn

article has not abstract

Zdroje

1. World Health Organization (2014) The End TB Strategy. Global strategy and targets for tuberculosis prevention, care and control after 2015. http://www.who.int/tb/post2015_TBstrategy.pdf?ua=1. Geneva: World Health Organization.

2. World Health Organization (2014) Global Tuberculosis Report 2014. Geneva: WHO. 1–289 p.

3. Qin ZZ, Pai M, Van Gemert W, Sahu S, Ghiasi M, et al. (2014) How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries? Eur Respir J 45 549–554. doi: 10.1183/09031936.00147714 25359338

4. World Health Organization (2015) WHO monitoring of Xpert MTB/RIF roll-out. http://www.who.int/tb/laboratory/mtbrifrollout/en/index.html. Accessed 5 February 2015.

5. TB CARE I (2014) International Standards for Tuberculosis Care, 3rd Edition. www.istcweb.org The Hague: TB CARE I, The Hague.

6. World Health Organization Country Office for India (2014) Standards for TB Care in India. http://tbevidence.org/wp-content/uploads/2014/04/STCI-2014.pdf

7. Wells WA, Boehme CC, Cobelens FG, Daniels C, Dowdy D, et al. (2013) Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action. Lancet Infect Dis 13 : 449–458. doi: 10.1016/S1473-3099(13)70025-2 23531393

8. Salje H, Andrews JR, Deo S, Satyanarayana S, Sun AY, et al. (2014) The Importance of Implementation Strategy in Scaling Up Xpert MTB/RIF for Diagnosis of Tuberculosis in the Indian Health-Care System: A Transmission Model. PLoS Med 11: e1001674. doi: 10.1371/journal.pmed.1001674 25025235

9. Pai M, Yadav P, Anupindi R (2014) Tuberculosis control needs a complete and patient-centric solution. Lancet Global Health 2: e189—e190. doi: 10.1016/S2214-109X(14)70198-6 25103049

10. Khan AJ, Khowaja S, Khan FS, Qazi F, Lotia I, et al. (2012) Engaging the private sector to increase tuberculosis case detection: an impact evaluation study. Lancet Infect Dis 12 : 608–616. doi: 10.1016/S1473-3099(12)70116-0 22704778

11. Volmink J, Garner P (2007) Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev: CD003343.

12. Dewan P (2015) How India is moving the needle on TB. http://www.impatientoptimists.org/Posts/2015/01/How-India-is-moving-the-needle-on-TB?utm_. Impatient Optimists. Seattle: Bill & Melinda Gates Foundation.

13. Laxminarayan R, Klein EY, Darley S, Adeyi O (2009) Global investments in TB control: economic benefits. Health Aff (Millwood) 28: w730–742. doi: 10.1377/hlthaff.28.4.w730 19567413

14. Wang L, Zhang H, Ruan Y, Chin DP, Xia Y, et al. (2014) Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data. Lancet 383 : 2057–2064. doi: 10.1016/S0140-6736(13)62639-2 24650955

15. Bagcchi S (2014) Indian government outlines plan to try to eliminate tuberculosis by 2020. BMJ 349: g6604. doi: 10.1136/bmj.g6604 25368389

16. Kalra A (2014) India slashes health budget, already one of the world's lowest. http://www.reuters.com/article/2014/12/23/us-india-health-budget-idUSKBN0K10XZ20141223. Reuters. New York: Thomson Reuters.